Neutrophil count measures the absolute number of neutrophils circulating in blood — the most abundant type of white blood cell and the first line of defence in innate immunity. Elevated neutrophils (neutrophilia) signal infection, inflammation, tissue injury, or stress response, whilst low neutrophils (neutropenia) indicate bone marrow suppression, certain medications, or immune deficiency. Neutrophil-to-lymphocyte ratio (NLR) is a validated prognostic marker in cardiovascular disease, oncology, and sepsis.
Analyzed in accredited Swedish clinical laboratories (ISO 15189). Used to support clinician-directed evaluation and monitoring. Not a stand-alone diagnosis.
This is a directly measured biomarker — automated haematology analysers measure neutrophil concentration as part of the standard complete blood count (CBC) differential.
If you have a fever, signs of infection, or are recovering from illness, your doctor already orders neutrophil count as part of routine screening. But for longevity baseline assessment and inflammation profiling, neutrophil count matters beyond acute diagnosis. A persistently elevated neutrophil count (even in the normal range) predicts cardiovascular events, metabolic dysfunction, and overall mortality. This is especially relevant if you have a family history of heart disease, metabolic syndrome, or chronic inflammation.
Neutrophil count also contextualizes immune capacity. Abnormally low neutrophils signal medication side effects, bone marrow stress, or nutritional deficiency — conditions that impair infection resistance and require investigation. Conversely, understanding your baseline neutrophil state and how it responds to training, stress, and lifestyle helps you track immune health in real time.
The neutrophil-to-lymphocyte ratio (NLR) — calculated by dividing absolute neutrophil count by lymphocyte count — is a validated inflammation and stress marker that independently predicts outcomes across cancer, cardiovascular disease, and sepsis. Testing neutrophils regularly gives you that calculation for free.
Flags infection and bacterial disease quickly. Elevated neutrophils (especially with immature forms like left shift) identify active bacterial infection, abscess, or other acute immune challenge requiring treatment.
Identifies medication and toxin effects. Certain drugs (trimethoprim-sulfamethoxazole, clozapine, methimazole, NSAIDs) cause neutropenia as a side effect; neutrophil monitoring guides safety management and drug continuation decisions.
Detects bone marrow suppression or failure. Severely low neutrophils (<0.5 × 10&sup9;/L) signal aplastic anaemia, leukaemia, or other haematologic emergency requiring urgent investigation.
Reveals chronic stress and inflammation burden. Persistently elevated neutrophils reflect ongoing metabolic stress, poor sleep, intense training overload, or chronic psychological strain — useful biofeedback for lifestyle adjustment.
Calculates neutrophil-to-lymphocyte ratio (NLR). NLR is an independent predictor of cardiovascular mortality, cancer prognosis, and sepsis severity. An NLR >7.5 even within normal individual counts signals elevated risk.
Monitors response to lifestyle and treatment. Neutrophil count drops with improved sleep, reduced stress, resolved infection, and systemic anti-inflammatory intervention, making it a useful real-time compliance and efficacy marker.
The biology of innate immunity's first responder. Neutrophils are polymorphonuclear leukocytes (PMNs) produced continuously in the bone marrow from myeloid progenitors. They circulate for 6–8 hours in the bloodstream, then migrate into tissues where they survive 1–3 days. Neutrophils are the first immune cells to arrive at a site of injury or infection, where they kill pathogens via phagocytosis and release antimicrobial peptides, enzymes, and reactive oxygen species. They are so numerous that a single neutrophil represents roughly 50–70% of all circulating white blood cells — far outnumbering lymphocytes, monocytes, and other leukocytes.
Why neutrophil count changes. Neutrophil production is tightly controlled by colony-stimulating factors (G-CSF, GM-CSF). Infection, inflammation, stress, and tissue injury trigger the bone marrow to release more neutrophils — both mature cells and immature precursors (a “left shift”). Conversely, bone marrow suppression (from chemotherapy, severe infection, autoimmune attack, or certain medications) reduces neutrophil output, causing neutropenia. Physical stress, extreme exercise, corticosteroid use, and acute infection can acutely demarginate neutrophils (shift them from the vessel wall to circulation) temporarily raising counts within hours.
The Duffy antigen and African ancestry context. A significant proportion of people of African ancestry carry the Duffy-null genotype (absence of the Duffy antigen on red blood cells). This genetic variant is associated with lower baseline neutrophil counts (often in the 2.0–4.0 × 10&sup9;/L range, lower than the standard reference). Importantly, this is not associated with increased infection risk and does not constitute neutropenia — it is a benign genetic polymorphism. If you have African ancestry and your neutrophils are “low” by standard reference ranges but you have no signs of infection or immune compromise, Duffy-null status may explain the difference. This is crucial context that should not trigger unnecessary investigation or treatment.
Neutrophil-to-lymphocyte ratio is a validated mortality predictor. The NLR — calculated as neutrophils divided by lymphocytes — independently predicts cardiovascular mortality, cancer prognosis, and sepsis severity across prospective cohort studies and RCTs. An NLR >7.5 even in people with normal individual counts is associated with worse outcomes in cardiology, oncology, and critical care. This single calculation derived from one CBC gives prognostic power comparable to specialist biomarkers.
Chronic low-grade neutrophilia signals metabolic and inflammatory stress. A persistently elevated neutrophil count (e.g., 7.5–9.0 × 10&sup9;/L without infection) reflects ongoing systemic inflammation from metabolic dysfunction, obesity, insulin resistance, poor sleep, or chronic psychological stress. This clustering is atherogenic — elevated neutrophils frequently co-occur with elevated hs-CRP, high ApoB, and elevated triglycerides, compounding cardiovascular risk.
Discordance between peripheral and tissue inflammation. A normal neutrophil count does not rule out tissue inflammation or infection; conversely, a very high count (e.g., 15–20 × 10&sup9;/L) may signal systemic bacterial infection requiring immediate intervention. Without concurrent clinical context (fever, localizing signs, CRP, procalcitonin), count alone is incomplete. This is why NLR offers more context than neutrophils alone.
Early detection of medication and bone marrow toxicity. Serial neutrophil monitoring catches drug-induced neutropenia before it becomes severe (agranulocytosis <0.5 × 10&sup9;/L), a medical emergency. Regular testing on potentially marrow-toxic drugs (clozapine, certain antibiotics, NSAIDs at high doses) enables safe drug continuation or early discontinuation.
Standard Swedish clinical reference (vårdcentralen): 1.8–7.5 × 10&sup9;/L. This is the typical reference range reported by Swedish clinical laboratories.
Loovi optimal (longevity baseline): 2.0–5.5 × 10&sup9;/L. This narrower range reflects a lower inflammatory and stress burden associated with better metabolic health and cardiovascular outcomes in primary prevention populations.
Neutropenia (medical alert): <1.5 × 10&sup9;/L; severe neutropenia <0.5 × 10&sup9;/L (agranulocytosis) is a medical emergency requiring immediate investigation and possible hospitalization.
The step from optimal (<5.5 × 10&sup9;/L) to elevated (5.5–7.5 × 10&sup9;/L) represents a shift in baseline immune activation and systemic stress burden. Values >7.5 × 10&sup9;/L, even without fever or obvious infection, suggest persistent low-grade inflammation worthy of investigation. When neutrophil count climbs above 9 × 10&sup9;/L in a previously stable person without active infection, seek clinical evaluation for metabolic derangement, smoking, chronic stress, or occult malignancy. For optimal longevity, aiming for the lower half of the standard range (2–5 × 10&sup9;/L) pairs well with fitness, good sleep, and metabolic health.
Low (<1.5 × 10&sup9;/L). This indicates a reduced circulating neutrophil pool and warrants investigation. Causes include bone marrow suppression (chemotherapy, aplastic anaemia, leukaemia), drug toxicity (trimethoprim-sulfamethoxazole, clozapine, methimazole, NSAIDs, certain antibiotics), severe infection (overwhelming sepsis consumes neutrophils faster than marrow produces them), or autoimmune destruction. Mild neutropenia (1.0–1.5 × 10&sup9;/L) may be benign and stable in some individuals (e.g., Duffy-null genotype in African ancestry). Moderate neutropenia (0.5–1.0 × 10&sup9;/L) increases infection risk and requires investigation. Severe neutropenia (<0.5 × 10&sup9;/L) is agranulocytosis — a medical emergency requiring immediate clinical evaluation and likely hospitalization.
Optimal (2.0–5.5 × 10&sup9;/L). This range indicates good immune capacity and low chronic inflammation burden. In the absence of recent infection, fever, or other immune stress, this range pairs well with metabolic health, fitness, quality sleep, and low psychological stress. Pair with lymphocyte count to calculate NLR; if NLR is <1.8, immune tone is excellent.
Elevated (5.5–7.5 × 10&sup9;/L). This range sits at the upper boundary of normal but indicates mild immune activation and systemic stress. Causes include recent or ongoing infection (viral, bacterial, fungal), inflammation (inflammatory bowel disease, vasculitis, rheumatoid arthritis), smoking, intense physical overtraining, chronic psychological stress, or metabolic dysfunction (obesity, insulin resistance). If a person has no fever or signs of acute infection, elevated neutrophils without symptoms reflect ongoing metabolic or stress burden. Investigate concurrent markers: is hs-CRP elevated? Is HbA1c or fasting insulin high? Is sleep quality poor? Addressing these drivers can lower neutrophil count.
Very High (>7.5 × 10&sup9;/L). Counts consistently >7.5 × 10&sup9;/L in the absence of fever or acute infection are unusual and warrant investigation. Causes include bacterial infection (abscess, pneumonia, endocarditis), active leukaemia or myeloproliferative disorder (chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia), severe stress or corticosteroid use, acute leukemoid reaction to tissue injury (post-myocardial infarction, post-surgery, acute trauma), smoking, or uncontrolled metabolic/autoimmune disease. Values >15 × 10&sup9;/L warrant urgent blood smear review and clinical assessment to exclude leukaemia or severe infection.
Factors that influence neutrophil count. Acute infection and fever raise neutrophils within hours; bacterial infection typically causes a more marked rise than viral. Intense exercise (sprinting, heavy resistance training) acutely raises neutrophils via catecholamine demargination; return to baseline within hours of recovery. Corticosteroid use acutely demarginalizes neutrophils; counts rise within hours and normalize within days of cessation. Psychological stress and sleep deprivation chronically elevate neutrophils over days to weeks. Smoking sustains mild neutrophilia; quitting lowers neutrophils over weeks to months. Pregnancy physiologically raises neutrophils; return to baseline post-partum. Recent vaccination, viral illness (even subclinical), or localized inflammation can elevate counts for days to weeks. Certain medications (epinephrine, lithium, G-CSF) raise counts; others (chemotherapy, immunosuppressants, certain antibiotics) lower them.
Infection and acute immune response. Bacterial infection triggers the fastest and largest neutrophil rise via G-CSF and IL-8 signalling from infected tissue and immune cells. Viral infections typically cause smaller, slower neutrophilia than bacterial; severe viral illness (influenza, COVID-19) can also elevate neutrophils significantly. Fungal and parasitic infections cause neutrophilia, though often with eosinophil elevation as well.
Inflammation and tissue injury. Post-myocardial infarction, acute surgery, severe burns, or acute inflammation (inflammatory bowel disease, vasculitis, rheumatoid arthritis) trigger rapid neutrophil elevation. The response peaks within 24–48 hours and slowly normalizes over days to weeks as inflammation resolves.
Metabolic dysfunction and chronic lifestyle stress. Obesity, insulin resistance, and metabolic syndrome chronically elevate neutrophils through sustained IL-6 and TNF-α signalling. Smoking causes persistent neutrophilia independent of acute infection; this is one reason smokers have higher cardiovascular risk. Chronic psychological stress and sleep deprivation elevate neutrophils over days to weeks via sympathetic activation and impaired immune tolerance.
Medications and bone marrow effects. Corticosteroids acutely demarginate neutrophils, raising counts. Long-term use can drive bone marrow hyperproduction. Certain drugs cause neutropenia via direct toxicity (trimethoprim-sulfamethoxazole, clozapine, methimazole, NSAIDs at high doses, certain antibiotics like penicillins) or immune-mediated destruction (agranulocytosis). Chemotherapy and radiation suppress bone marrow output, causing neutropenia.
Genetic and benign factors. Duffy-null genotype, common in African ancestry, lowers baseline neutrophil count without increasing infection risk. Certain individuals have constitutive benign neutropenia (<1.5 × 10&sup9;/L without symptoms), likely genetically determined; this requires no treatment. Conversely, myeloproliferative disorders (chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia) cause persistent marked neutrophilia (>15 × 10&sup9;/L) from clonal bone marrow expansion.
Infection control and immune resilience. The most direct driver of elevated neutrophils is unresolved or recurrent infection. Preventing infection through hand hygiene, vaccination (influenza, pneumococcal), and prompt treatment of localized infections (dental, skin, urinary tract) keeps neutrophils from rising unnecessarily. Building immune resilience via adequate sleep (7–9 hours), regular physical activity, and stress management reduces the frequency of viral infections and transient neutrophilia.
Sleep, stress management, and metabolic health. Chronically elevated neutrophils in the absence of infection reflect metabolic stress and poor sleep. Prioritizing 7–9 hours of quality sleep lowers neutrophils within days to weeks. Psychological stress reduction (meditation, yoga, deliberate relaxation) lowers both cortisol and neutrophil count. Weight loss and improved insulin sensitivity (via reduced refined carbohydrates, increased physical activity, and adequate sleep) reliably lower neutrophils in obese or metabolically dysfunctional individuals. Quitting smoking lowers neutrophils over weeks to months.
Training and physical activity. Regular moderate-intensity aerobic exercise and resistance training improve metabolic health and lower baseline neutrophil count independent of weight loss. Avoid sustained overtraining and excessive volume without adequate recovery, which elevates inflammatory markers including neutrophils. The balance between training stimulus and recovery is key; poor recovery and high cumulative fatigue sustain elevated neutrophils.
Nutrition and metabolic drivers. Reducing ultraprocessed foods, refined carbohydrates, and excessive sugar lowers postprandial insulin spikes and IL-6 secretion, reducing neutrophil elevation. Adequate protein intake (1.2–1.6 g/kg body weight) supports recovery and metabolic stability. Omega-3 fatty acids (EPA/DHA from fish or algae supplements) have mild anti-inflammatory effects. Micronutrient sufficiency (iron, B12, folate) is essential for bone marrow neutrophil production; deficiency causes impaired output.
Medication safety and monitoring. If you are taking a drug known to cause neutropenia, regular neutrophil monitoring (every 2–4 weeks initially, then as clinically indicated) enables early detection of toxicity before agranulocytosis develops. Some drugs (e.g., clozapine for schizophrenia) require mandatory absolute neutrophil count monitoring before initiation and regularly thereafter. If neutropenia develops, your clinician may adjust dose or discontinue the drug.
The right approach depends on your baseline neutrophil count, current infection/inflammation status, medications, fitness level, sleep quality, and metabolic markers (HbA1c, triglycerides, ApoB) — exactly the kind of personalized synthesis that a Loovi longevity doctor conducts in consultation. Neutrophil count alone does not prescribe action; context determines intervention.
Neutrophil count in isolation tells an incomplete story. An elevated count could indicate acute infection (requiring treatment), metabolic stress (requiring lifestyle change), medication toxicity (requiring discontinuation), or myeloproliferative disease (requiring specialist evaluation). Without concurrent clinical signs (fever? respiratory symptoms? fatigue?), other white blood cell counts (lymphocytes, monocytes), and inflammation markers (hs-CRP, ESR), you cannot distinguish between these possibilities.
Neutrophil-to-lymphocyte ratio (NLR) offers better prognostic power than neutrophils alone. An NLR >7.5 independently predicts cardiovascular mortality and cancer prognosis. But even NLR requires context from concurrent markers: is HbA1c elevated? Is ApoB high? Is hs-CRP raised? Is your WBC differential showing a left shift (immature neutrophils)? These patterns tell you whether you are dealing with acute infection, chronic metabolic stress, or systemic disease.
The Loovi Membership measures 120+ biomarkers annually, including the complete blood count differential (neutrophils, lymphocytes, monocytes, eosinophils, basophils), inflammation markers (hs-CRP, ESR), metabolic markers (HbA1c, fasting glucose, fasting insulin, ApoB), and many others. Paired with unrushed 1-on-1 longevity doctor consultations, physical performance tests (strength, mobility, VO2 max), and an evolving personalized health plan, Loovi hands off the hard work of interpretation to clinical experts. From 295 SEK/month, Friskvårdsbidrag-approved, with drop-in testing at 80+ Swedish clinics and results in 3 days.
Asymptomatic neutrophilia most often reflects metabolic stress, chronic inflammation, smoking, psychological stress, sleep deprivation, intense training overload, or hormonal shifts. Check concurrent markers: if hs-CRP is also elevated, metabolic or inflammatory dysfunction is driving the rise. If HbA1c and fasting insulin are high, insulin resistance is a major driver. If you are a smoker, quitting will lower neutrophils reliably. If sleep is poor or stress is chronic, improving these can lower counts within days to weeks. Asymptomatic persistent neutrophilia (>7.5 × 10&sup9/L lasting weeks) warrants investigation for occult infection (urinary tract, dental, pulmonary) or systemic disease (autoimmune, myeloproliferative).
NLR is calculated by dividing absolute neutrophil count by absolute lymphocyte count. An NLR >7.5 is associated with worse cardiovascular outcomes, cancer prognosis, and mortality risk independent of either count alone. For example, two people might both have neutrophil counts in the normal range, but if one has low lymphocytes (high NLR) and the other has high lymphocytes (low NLR), the first has worse long-term risk. NLR improves prognostic accuracy in cardiology, oncology, and critical care. Every CBC gives you this calculation for free; calculate it yourself by dividing your neutrophil count by your lymphocyte count.
Yes. Very intense exercise (sprints, heavy lifting, high-intensity interval training) causes acute catecholamine surge, which demarginalizes neutrophils from the vessel wall into circulation. Neutrophil count rises within 30 minutes of intense effort and returns to baseline within hours of recovery. This is a normal physiologic response and does not indicate infection or disease. For the most valid baseline neutrophil measurement, test at least 24–48 hours after your last hard training session.
Agranulocytosis is severe neutropenia (<0.5 × 10&sup9/L). With so few neutrophils circulating, the body cannot mount an effective first-line immune defence against bacteria. Normally, a minor scratch or dental bacteria are handled instantly by abundant neutrophils. In agranulocytosis, these minor bacterial exposures can rapidly become life-threatening sepsis or overwhelming infection. This is why drug-induced agranulocytosis (from clozapine, trimethoprim-sulfamethoxazole, certain other medications) is a medical emergency requiring hospitalization, broad-spectrum antibiotics, and often G-CSF (granulocyte-colony-stimulating factor) to accelerate bone marrow recovery. If you develop sudden fever, sore throat, or oral ulcers while taking a medication known to cause neutropenia, seek emergency care immediately.
Corticosteroids acutely raise neutrophil count by demarginating neutrophils from the vessel wall into circulation within 2–4 hours. This elevation is transient; if steroid use stops, counts return to baseline within 12–24 hours. However, chronic corticosteroid use can impair immune function and increase infection risk paradoxically. If you require systemic steroids (e.g., for autoimmune disease, severe allergic reaction, or transplant rejection), neutrophil count will rise acutely, but your actual infection resistance is diminished. Do not interpret elevated neutrophils from steroids as a sign of strong immunity; the opposite is often true.
Neutrophil count is part of the standard complete blood count (CBC or differential white cell count), which is routinely performed by any Swedish vårdcentral if clinically indicated (fever, infection, follow-up of a previous abnormality, etc.). You do not need a private lab for this test — it is part of standard care. However, if you want a baseline longevity assessment without a clinical indication (symptoms or prior abnormality), your vårdcentral may not order it. Loovi measures CBC differential as part of the standard annual biomarker panel, so you get neutrophil count alongside 120+ other markers.
A left shift is the presence of immature neutrophil precursors (bands, metamyelocytes, myelocytes) in the circulating blood. Normally, only mature neutrophils are released from the bone marrow. A left shift occurs when the marrow is so activated by infection or stress that it releases immature forms before they are fully mature. A left shift signals acute bacterial infection, severe stress response, or leukemia. If your report mentions left shift, the degree is important: a mild left shift with infection is expected and benign. A marked left shift (>30% immature forms) warrants urgent investigation for leukemia, severe infection, or leukemoid reaction.
Yes, in a benign way. The Duffy antigen is found on red blood cells and white blood cells, and certain populations (especially people of African ancestry) carry a Duffy-null genotype (complete absence of the antigen). This genetic variant is associated with baseline neutrophil counts that are lower than typical reference ranges — often 2.0–4.0 × 10&sup9/L instead of the 1.8–7.5 range. The critical point: this does not impair infection resistance or immune function. Duffy-null individuals do not have more infections; they simply have a genetically lower set point. If you have African ancestry and your neutrophil count is “low” by standard reference ranges but you have no infection history or immune symptoms, Duffy-null status likely explains the difference. Treat it as benign and avoid unnecessary investigation or treatment.
Yes. Smokers have persistently elevated neutrophil counts (often 6–8 × 10&sup9/L or higher) due to ongoing airway inflammation and oxidative stress. This is one reason smokers have elevated cardiovascular risk — chronic neutrophilia pairs with elevated hs-CRP, endothelial dysfunction, and thrombotic tendency. Quitting smoking lowers neutrophil count over weeks to months as airway inflammation resolves. If you are a smoker with elevated neutrophils, cessation is one of the highest-yield interventions for lowering both counts and cardiovascular risk.
hs-CRP and neutrophil count measure different facets of inflammation. hs-CRP reflects vascular inflammation and the liver's response to IL-6 signalling; it is slower to change but more specific to chronic cardiovascular risk. Neutrophil count reflects bone marrow activation and acute/subacute immune response; it is more sensitive to acute triggers (infection, exercise, stress) but less predictive of chronic disease alone. Together, they paint a fuller picture: elevated hs-CRP with elevated neutrophils suggests persistent inflammatory burden from metabolic dysfunction or chronic infection. Elevated neutrophils with low hs-CRP suggests acute immune activation (recent infection, intense training, stress response). Both together improve risk stratification beyond either alone.
